Evidence map›Paper›PMID 41640580›Full record

ArticleFrontiers in cardiovascular medicine2025

HFA-PEFF score as a predictor of worsening heart failure after first-time catheter ablation for atrial fibrillation in patients with preclinical heart failure and preserved ejection fraction.

Sho Hirayama, Shinya Fujiki, Ami Maekawa, Soma Sato, Hayao Ikesugi, Kazuyo Tanaka, Yuka Sekiya, Hiroki Tsuchiya, Takayuki Kumaki, Naomasa Suzuki and 8 more

Abstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Sho HirayamaDepartment of Cardiovascular and Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Shinya FujikiDepartment of Cardiovascular and Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Ami MaekawaSchool of Medicine, Niigata University, Niigata, Japan.
Soma SatoDepartment of Cardiovascular and Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Hayao IkesugiDepartment of Cardiovascular and Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Kazuyo TanakaDepartment of Cardiovascular and Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Yuka SekiyaDepartment of Cardiovascular and Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Hiroki TsuchiyaDepartment of Cardiovascular and Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Takayuki KumakiDepartment of Cardiovascular and Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Naomasa SuzukiDepartment of Cardiovascular and Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Ryohei SakaiDepartment of Cardiovascular and Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Yasuhiro IkamiDepartment of Cardiovascular and Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Yuki HasegawaDepartment of Cardiovascular and Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Sou OtsukiDepartment of Cardiovascular and Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Hiromi KayamoriDepartment of Cardiovascular and Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Tsugumi TakayamaDepartment of Cardiovascular and Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Takeshi KashimuraDepartment of Cardiovascular and Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Takayuki InomataDepartment of Cardiovascular and Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Catheter ablation (CA) is a standard treatment for atrial fibrillation (AF); however, some patients experience worsening heart failure (WHF) afterward. The H Method: This retrospective, single-center observational study included 257 AF patients with preserved left ventricular ejection fraction (LVEF) ≥50% and no history or symptoms of HF who underwent first-time CA between February 2017 and September 2022. Patients were classified as high HFpEF score group if they had H Results: Among 257 patients, 54 (21.01%) were classified as high HFpEF score group. WHF incidence was significantly higher in the high HFpEF score group than in the low HFpEF score group (log-rank Conclusions: In this exploratory analysis, the HFA-PEFF score potentially represent an independent predictor of WHF after CA in AF patients with preclinical HF and preserved LVEF.

Indexed as

atrial fibrillationcatheter ablationH2FPEF scoreHFA-PEFF scoreHFpEF

Identifiers

PMID41640580
PMCPMC12864457

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.